Suppr超能文献

儿童快速进展性肾小球肾炎

Rapidly progressive glomerulonephritis in children.

作者信息

Moorani Khemchand N, Aziz Madiha, Amanullah Farhana

机构信息

Khemchand N Moorani, MBBS, FCPS (Pediatrics and Nephrology). Professor of Pediatric Nephrology, The Kidney Center Postgraduate Training Institute (TKCPGTI), Karachi, Pakistan.

Madiha Aziz, MBBS, FCPS (Pediatrics and Nephrology). Pediatric Nephrologist, Sindh Institute of Urology & Transplantation, Karachi, Pakistan.

出版信息

Pak J Med Sci. 2022 Jan;38(2):417-425. doi: 10.12669/pjms.38.ICON-2022.5774.

Abstract

Rapidly progressive glomerulonephritis (RPGN), characterized by a rapid development of nephritis with loss of kidney function in days or weeks, is typically associated histologically, with crescents in most glomeruli; and is a challenging problem, particularly in low resource settings. RPGN is a diagnostic and therapeutic emergency requiring prompt evaluation and treatment to prevent poor outcomes. Histopathologically, RPGN consists of four major categories, anti-glomerular basement membrane (GBM) disease, immune complex mediated, pauci-immune disorders and idiopathic /overlap disorders. Clinical manifestations include gross hematuria, proteinuria, oliguria, hypertension and edema. Diagnostic evaluation, including renal function tests, electrolytes, urinalysis/microscopy and serology including (anti GBM antibody, antineutrophil cytoplasmic antibody (ANCA)) starts simultaneously with management. An urgent renal biopsy is required to allow specific pathologic diagnosis as well as to assess disease activity and chronicity to guide specific treatment. The current guidelines for management of pediatric RPGN are adopted from adult experience and consist of induction and maintenance therapy. Aggressive combination immunosuppression has markedly improved outcomes, however, nephrotic syndrome, severe acute kidney injury requiring dialysis, presence of fibrous crescents and chronicity are predictors of poor renal survival. RPGN associated post infectious glomerulonephritis (PIGN) usually has good prognosis in children without immunosuppression whereas immune-complex-mediated GN and lupus nephritis (LN) are associated with poor prognosis with development of end stage kidney disease (ESKD) in more than 50% and 30% respectively. Given the need for prompt diagnosis and urgent treatment to avoid devastating outcomes, we conducted a review of the latest evidence in RPGN management to help formulate clinical practice guidance for children in our setting. The search strategy was performed in the digital databases of PubMed, Cochrane Library, google scholar, from their inception dates to December 2020. Three investigators independently performed a systematic search using the following search terms "Rapidly progressive glomerulonephritis" "children" "crescentic glomerulonephritis" "management" at the same time, backtracking search for references of related literature.

摘要

快速进展性肾小球肾炎(RPGN)的特点是肾炎迅速发展,在数天或数周内肾功能丧失,组织学上通常表现为大多数肾小球出现新月体;这是一个具有挑战性的问题,尤其是在资源匮乏的地区。RPGN是一种诊断和治疗的紧急情况,需要及时评估和治疗以防止不良后果。组织病理学上,RPGN主要分为四类,即抗肾小球基底膜(GBM)病、免疫复合物介导型、寡免疫性疾病和特发性/重叠性疾病。临床表现包括肉眼血尿、蛋白尿、少尿、高血压和水肿。诊断评估,包括肾功能测试、电解质、尿液分析/显微镜检查和血清学检查(包括抗GBM抗体、抗中性粒细胞胞浆抗体(ANCA))与治疗同时开始。需要进行紧急肾活检以进行特异性病理诊断,并评估疾病活动度和慢性程度以指导具体治疗。目前儿童RPGN的管理指南借鉴了成人经验,包括诱导治疗和维持治疗。积极的联合免疫抑制显著改善了治疗效果,然而,肾病综合征、需要透析的严重急性肾损伤、纤维性新月体的存在和慢性化是肾脏存活率低的预测因素。RPGN相关的感染后肾小球肾炎(PIGN)在儿童中通常在不进行免疫抑制的情况下预后良好,而免疫复合物介导的肾小球肾炎和狼疮性肾炎(LN)预后较差,分别有超过50%和30%的患者发展为终末期肾病(ESKD)。鉴于需要及时诊断和紧急治疗以避免灾难性后果,我们对RPGN管理的最新证据进行了综述,以帮助制定我们所在地区儿童的临床实践指南。检索策略在PubMed、Cochrane图书馆、谷歌学术的数字数据库中进行,检索时间从其创建日期至2020年12月。三名研究人员同时使用以下检索词“快速进展性肾小球肾炎”“儿童”“新月体性肾小球肾炎”“管理”进行系统检索,并回溯搜索相关文献的参考文献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2cc4/8899892/cfe02773f082/PJMS-38-417-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验